Organovo Holdings Inc news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

ONVO 2.71 +0.03 (1.12%)
price chart
Why Organovo Holdings Inc Shareholders Have Something to Worry About
Small-cap start-up Organovo Holdings Inc (NASDAQ:ONVO) may be one of the most interesting companies in the healthcare sector.
Organovo Holdings Inc. (ONVO) Moves Lower on Volume Spike for April 18  Equities.com
Lookout for Price Target? TripAdvisor, Inc. (TRIP), Organovo Holdings, Inc ...  StockNewsJournal
What's Next for Organovo Holdings Inc.?
There was one big reason behind Organovo's drop earlier this year. The company slashed its fiscal-year 2017 revenue guidance in February, from a range of $4.5 million to $6.2 million to a range of $3.7 million to $4.5 million.
Organovo Announces CEO Transition  GlobeNewswire (press release)
Organovo (ONVO) CEO Keith Murphy to Step Down, Will Remain Chairman; Taylor ...  StreetInsider.com
Why Organovo Holdings Inc. Is Up 27% This Year
What: Shareholders of Organovo Holdings (NASDAQ:ONVO), a 3-D bioprinting technology company, are having a great 2016.
What to Expect in Organovo Holdings Inc. Q3 Results
Organovo Holdings (NASDAQ:ONVO) announces its fiscal third-quarter results on Feb. 9 after the market closes. The 3-D bioprinting company posted record numbers in the second quarter, so shareholders have high expectations.
Insider Trading Activity Organovo Holdings, Inc. (NASDAQ:ONVO) – CEO Sold ...  Market Exclusive
Will 2017 Be Organovo Holdings, Inc.'s Best Year Yet?
Organovo Holdings (NASDAQ:ONVO) stock appears to be on its way to posting its third-best performance in the history of the company.
How Risky Is Organovo Holdings, Inc.?
What a difference a year makes. In 2015, Organovo Holdings (NASDAQ:ONVO) lost nearly two-thirds of its market cap. This year, though, the 3D bioprinting leader's stock is up over 50% so far.
Better Buy: Organovo Holdings, Inc. vs. Akebia Therapeutics, Inc.
At first glance, Organovo Holdings (NASDAQ:ONVO) versus Akebia Therapeutics (NASDAQ:AKBA) might seem like an apples-and-oranges comparison.
Organovo Holdings Inc.'s 36% Ascent in 2016 Can Be Attributed to These 3 Factors
Shares of Organovo Holdings (NASDAQ:ONVO), a life sciences company primarily focused on the development of bioengineered human tissues for the pharmaceutical and research industries, surged 36% in 2016 according to data from S&P Global Market ...
5 Things Organovo Holdings, Inc. Management Wants You to Know
Financial figures didn't cause anyone to perform cartwheels after Organovo Holdings (NASDAQ:ONVO) reported its 2016 fourth-quarter results on June 9. A quarterly loss of $8.4 million with revenue of only $0.5 million isn't awfully exciting.
Organovo Collaborates With UCSF Team to Develop 3D Bioprinted Tissues for ...  GlobeNewswire (press release)
Organovo Holdings, Inc.'s Biggest Win in 2016
In September, Organovo announced the launch of its second commercial product, ExVive human kidney tissue. This kidney tissue enables customers to study the effects of drug exposure in the human kidney as part of their drug discovery and development ...
Organovo Signs Exclusive Distributor Agreement With Cosmo Bio (Japan)  GlobeNewswire (press release)
What made Organovo Holdings Inc (NASDAQ:ONVO) win 2016 in the market?  FinancialsTrend